ASH HIGHLIGHTS 2024 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSIONS: Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T in RRMM

OR
Please enter your username or email address. You will receive an email message to log in.
Explore more from your favourite experts – click their name to access their entire library of content.
Studies / Trials Discussed
Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T in RRMM
Studies/trials discussed:
Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T in RRMM
©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.